You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Colorcon
Boehringer Ingelheim
Johnson and Johnson
Baxter

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Immune globulin intravenous (human) - Biologic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for immune globulin intravenous (human)
Tradenames:3
Patents:12
Applicants:3
BLAs:3
Suppliers: see list4
Recent Clinical Trials: See clinical trials for immune globulin intravenous (human)
Recent Clinical Trials for immune globulin intravenous (human)

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Grifols Therapeutics LLCPhase 2
Instituto Grifols, S.A.Phase 2
Instituto Nacional de Cancerologia de MexicoPhase 2

See all immune globulin intravenous (human) clinical trials

Patent Text Search: US Patents for immune globulin intravenous (human)

These patents were identified by searching patent claims
Glossary
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Grifols Usa, Llc FLEBOGAMMA DIF immune globulin intravenous (human) INJECTION, SOLUTION 125077 1 2010-07-27   Start Trial University of Georgia Research Foundation, Inc. (Athens, GA) 2029-12-07 search
Grifols Usa, Llc FLEBOGAMMA DIF immune globulin intravenous (human) INJECTION, SOLUTION 125077 1 2010-07-27   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2033-03-11 search
Grifols Usa, Llc FLEBOGAMMA DIF immune globulin intravenous (human) INJECTION, SOLUTION 125077 1 2010-07-27   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2029-05-13 search
Grifols Usa, Llc FLEBOGAMMA DIF immune globulin intravenous (human) INJECTION, SOLUTION 125077 1 2010-07-27   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2033-03-11 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Moodys
Mallinckrodt
Merck
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2020 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2020 - 2021
 NCE-1 Patent Challenge Dates 2020 - 2021
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2020, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group